Home>Topics>Stocks>Somaxon Pharmaceuticals

Somaxon Pharmaceuticals SOMX

  1. All
  2. Commentary
  3. Headlines
    1. Jazz Pharmaceuticals Can Hit An Interesting Note In 2012

      Headlines

      Sun, 26 Feb 2012

      By Jessica King Holden : Jazz Pharmaceuticals ( JAZZ ) caught a lot of buzz in 2011 amid a rumored buyout by Pfizer ( PFE ), which turned out to be a confirmation of a merger with Irish Pharmaceutical Azur Pharma. While news of a Pfizer buyout could have offered shareholders one of the sought after

    2. UPDATE 1-Somaxon to explore strategic options, cut jobs

      Headlines

      Mon, 19 Dec 2011

      Dec 19 (Reuters) - Somaxon Pharmaceuticals Inc said it was exploring strategic alternatives, including a sale, and will cut jobs to conserve cash.

    3. Somaxon Pharmaceuticals ( SOMX ) jumps in post-trade after saying it had a productive meeting with the FDA relating to the over-the-counter development program for its insomnia drug Silenor, developed ...

      Headlines

      Mon, 3 Oct 2011

      Somaxon Pharmaceuticals ( SOMX ) jumps in post-trade after saying it had a productive meeting ..... drug Silenor, developed jointly with Proctor & Gamble ( PG ). SOMX +22.5% AH. Post your comment!

    4. What Happens After Intermezzo's Likely FDA Approval

      Headlines

      Mon, 11 Jul 2011

      Smith On Stocks submits: Transcept’s ( TSPT ) new drug for insomnia, Intermezzo, received a Complete Response Letter on October 26, 2009, in which the FDA acknowledged that it was effective. However, the agency failed to approve the drug because of concerns about dosing and potential next day ...

    5. Somaxon Is a Sleeper in the Insomnia Market

      Headlines

      Tue, 24 May 2011

      Len Zehr submits: Somaxon Pharmaceuticalssomx (NASDAQ: SOMX ) is burning the midnight oil to get its message out about the safety and efficacy of Silenor, its recently launched drug to treat

    6. UPDATE 1-Somaxon sues Actavis over generic insomnia drug

      Headlines

      Tue, 10 May 2011

      May 10 (Reuters) - Somaxon Pharmaceuticals Inc said it filed a lawsuit against Icelandic generic drugmaker Actavis, challenging its application to make a copycat version of Somaxon's insomnia drug, Silenor.

    7. Premarket gainers: [[VRTX]] +17%. [[OCLR]] +10%. [[CHS]] +5%. [[DTV]] +6%. [[CTIC]] +5%. [[SNV]] +4%. [[ SOMX ]] +4%.Losers: [[SATC]] -14%. [[HPQ]] -9%. [[CNXT]] -6%. [[GRMN]] -6%.

      Headlines

      Wed, 23 Feb 2011

      Premarket gainers: VRTX +17% . OCLR +10% . CHS +5% . DTV +6% . CTIC +5% . SNV +4% . SOMX +4% . Losers: SATC -14% . HPQ -9% . CNXT -6% . GRMN -6% . Post your comment!

    8. UPDATE 1-Somaxon gets closer to insomnia drug patent

      Headlines

      Tue, 22 Feb 2011

      FEB 22 (Reuters) - Somaxon Pharmaceuticals Inc said the U.S. Patent and Trademark Office intends to issue a patent for the company's insomnia drug, Silenor, which has recently seen generic threat.

    9. Premarket gainers: [[RHB]] +46%. [[KND]] +26%. [[CNXT]] +17%. [[XIDE]] +15%. [[ SOMX ]] +6%. [[CXZ]] +5%. [[CPST]] +5%. [[MT]] +5%. [[BYD]] +4%. [[MGM]] +4%. [[NTWK]] +4%. [[MOTR]] +4%. [[CCME]] ...

      Headlines

      Tue, 8 Feb 2011

      Premarket gainers: RHB +46% . KND +26% . CNXT +17% . XIDE +15% . SOMX +6% . CXZ +5% . CPST +5% . MT +5% . BYD +4% . MGM +4% . NTWK +4% . MOTR +4% . CCME +4% . Losers: BR -12

    10. Somaxon Pharmaceuticals : Will FDA Approval Ever Pay Off?

      Headlines

      Wed, 26 Jan 2011

      Bert Wilkison submits: It has been nearly a year since Somaxon Pharmaceuticals ( SOMX ) received FDA approval for its lead product, Silenor, for the treatment of insomnia characterized by difficulty with sleep maintenance

    « Prev123Next »
    Content Partners